@DrMarthaGulati A tremendous and unexpected loss for our academic and clinical practice cardiology community. Amir has been a giant in our field of CAD management!
@DavidLBrownMD But he fits the key Cabinet recruitment criteria for being a disrupter and otherwise lacking the requisite experience and credentials of the department he is tasked to lead.
@EricTopol@NatureMedicine These impt findings are c/w what has been observed since the COURAGE Trial in 2007 and BARI-2D in 2009 that multifaceted secondary prevention + lifestyle changes (OMT) alone reduce death/MI, but are achieved in <15-20% patients in routine practice. Why such low implementation?
@heartdr_kabir @CircOutcomes@Nobu0129@MidAmericaHeart@maggioni5@W66588221White @FaRodriguezMD @SripalBangalore The totality of evidence derived from all the recent trials since 2000 shows that, for CV event reduction, PCI combined with OMT (secondary prevention + life style change) is not superior to OMT alone. As we’ve also known for 30+ years, revasc. Is better for angina relief & QOL.
@drjohnm@DavidLBrownMD@djc795 And we lack compelling evidence of benefit for CV event reduction with PCI except in high-risk anatomic subsets, and which are the minority of stable CAD patients. Plus, despite the proven benefits of OMT, it remains woefully underutilized in practice. Why?
@JJheart_doc @MGHHeartHealth A truly remarkable man and selfless physician who inspired both colleagues and trainees, and who was the consummate clinical cardiologist to so many patients who were fortunate to receive his care. He leaves an immense legacy which you and others will carry forward.